首页> 外国专利> Method of treating angina pectoris, coronary insufficiency, and preventing myocardial infarction

Method of treating angina pectoris, coronary insufficiency, and preventing myocardial infarction

机译:治疗心绞痛,冠状动脉供血不足和预防心肌梗塞的方法

摘要

A method of treating angina pectoris (i.e., suppressing the incidence of angina and relieving the painful symptoms of anginal attacks, treating coronary insufficiency and suppressing the incidence of myocardial infarction in living beings by increasing coronary blood flow by blocking the sympathetic nervous system by administration of a post-ganglionic sympathetic blocking agent. Bretylium tosylate, bethanidine and guanethidine are among the drugs known to have post-ganglionic sympathetic blocking properties. The drug is preferably administered prophylactically in angina-prone patients in advance of an anginal episode but it may also be given to shorten the duration and relieve the pain of an anginal attack in progress. In patients with signs and symptoms of acute coronary insufficiency and acute myocardial infarction, the prompt induction of sympathetic blockade will prevent and/or minimize the death of heart muscle (myocardial infarction).
机译:一种治疗心绞痛的方法(即抑制心绞痛的发生并缓解心绞痛发作的痛苦症状,治疗冠状动脉供血不足以及通过增加冠状动脉血流量来增加生物通量,从而通过抑制交感神经系统来抑制心肌梗塞的发生率。甲苯磺酸丁二醇酯,山than啶和胍乙啶是已知具有神经节后交感神经阻滞特性的药物,该药物优选在易发生心绞痛的患者中在发生心绞痛之前进行预防性给药,但也可能是在有急性冠状动脉供血不足和急性心肌梗塞的体征和症状的患者中,及时诱导交感神经阻滞将预防和/或最小化心肌(心肌)的死亡梗死)。

著录项

  • 公开/公告号US3911125A

    专利类型

  • 公开/公告日1975-10-07

    原文格式PDF

  • 申请/专利权人 BACANER;MARVIN B.;

    申请/专利号US19730363012

  • 发明设计人 BACANER;MARVIN B.;

    申请日1973-05-23

  • 分类号A61K31/14;A61K31/155;A61K31/33;

  • 国家 US

  • 入库时间 2022-08-23 03:25:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号